Regulation of Cell Growth and Proliferation in Metazoans by mTOR and the p70 S6 Kinase

Handbook of Cell Signaling: Volume 1-3

Volumn 1-3, Issue , 2003, Pages 523-534

  Avruch, Joseph ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 11144300980     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012124546-7/50448-4     Document Type: Chapter

References (136)

1. S. Schreiber (1991) Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251 283-287.
2. F.J. Dumont and G. Su (1995) Mechanism of action of the immuno-suppressant rapamycin. Life Sci. 58 373-395.
3. R.T. Abraham and G.J. Wiederrecht (1996) Immunopharmacology of rapamycin. Ann. Rev. Immunol. 14 483-510.
4. J. Kunz, R. Henriquez, U. Schneider, M. Deuter-Reinhard, N.R. Movva and M.N. Hall (1993) Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73 585-596.
5. R. Cafferkey, P.R. Young, M.M. McLaughlin, D.J. Bergsma, Y. Koltin, G.M. Sathe, L. Faucette, W.K. Eng, R.K. Johnson and G.P. Livi (1993) Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol. Cell Biol. 13 6012-6023.
6. E.J. Brown, M.W. Albers, T.B. Shin, K. Ichikawa, C.T. Keith, W.S. Lane and S.L. Schreiber (1994) A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369 756-758.
7. D.M. Sabatini, H. Erdjument-Bromage, M. Lui, P. Tempst and S.H. Snyder (1994) RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78 35-43.
8. M.I. Chiu, H. Katz and V. Berlin (1994) RAPT1, a mammalian homolog of yeast TOR, interacts with the FKBP12/rapamycin complex. Proc. Natl. Acad. Sci. USA 91 12574-12578.
9. C.J. Sabers, M.M. Martin, G.J. Brunn, J.M. Williams, F.J. Dumont, G. Wiederrecht and R.T. Abraham (1995) Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J. Biol. Chem. 270 815-822.
10. N.C. Barbet, U. Schneider, S.B. Helliwell, I. Stansfield, M.F. Tuite and M.N. Hall (1996) TOR controls translation initiation and early G1 progression in yeast. Mol. Biol. Cell 7 25-42.
11. Y. Ohsumi (2001) Molecular dissection of autophagy: two ubiquitin-like systems. Nat. Rev. Mol. Cell Biol. 2 211-216.
12. J.S. Hardwick, F.G. Kuruvilla, J.K. Tong, A.F. Shamji and S.L. Schreiber (1999) Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the TOR proteins. Proc. Natl. Acad. Sci. USA 96 14866-14870.
13. M.E. Cardenas, N.S. Cutler, M.C. Lorenz, C.J. Di Como and J. Heitman (1999) The TOR signaling cascade regulates gene expression in response to nutrients. Genes Devel. 13 3271-3279.
14. A.F. Shamji, G. Finny, G. Kuruvilla and S.L. Schreiber (2000) Partitioning the transcriptional program induced by rapamycin among the effectors of the TOR proteins. Curr. Biol. 10 1574-1581.
15. X. Long, C. Spycher, S.Z. Han, A.M. Rose, F. Müller and J. Avruch (2002) TOR deficiency in C. elegans causes developmental arrest and intestinal atrophy by inhibition of mRNA translation. Curr. Biol. 12 1448-1461.
16. A.-C. Gingras, B. Raught and N. Sonenberg (2001) Regulation of translational initiation by FRAP/mTOR. Genes Dev. 15 807-826.
17. D.C. Fingar, S. Salama, C. Tsou, E. Harlow and J. Blenis (2002) Mammalian cell size is controlled by mTOR and its dowstream targets S6K2 and 4EBP1/eIF4E. Genes Dev. 16 1472-1487.
18. C. Rommel, S.C. Bodine, B.A. Clarke, R. Rossman, L. Nunez, T.N. Stitt, G.D. Yancopoulos and D.J. Glass (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell. Biol. 3 1009-1013.
19. S.C. Bodine, T.N. Stitt, M. Gonzalez, W.O. Kline, G.L. Stover, R. Bauerlein, E. Zlotchenko, A. Scrimgeour, J.C. Lawrence, D.J. Glass and G.D. Yancopoulos (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3 1014-1019.
20. T. Shioi, J.R. McMullen, P.M. Kang, P.S. Douglas, T. Obata, T.F. Franke, L.C. Cantley and S. Izumo (2002) Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell. Biol. 22 2799-2809.
21. A.L. Edinger and C.B. Thompson (2002) Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 13 2276-2288.
22. J. Montagne, M.J. Stewart, H. Stocker, E. Hafen, S.C. Kozma and G. Thomas (1999) Drosophila S6 kinase: a regulator of cell size. Science 285 2126-2129.
23. R.P. de Groot, L.M. Ballou and P. Sassone-Corsi (1994) Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen-induced gene expression. Cell 79 81-91.
24. K.F. Wilson, W.J. Wu and R.A. Cerione (2000) Cdc42 stimulates RNA splicing via the S6 kinase and a novel S6 kinase target, the nuclear cap-binding complex. J. Biol. Chem. 275 37307-37310.
25. X. Wang, W. Li, M. Williams, N. terada, D.R. Alessi and C.G. Proud (2001) Regulation of elongation factor 2 kinase by p90 (RSK1) and p70 S6 kinase. EMBO J. 20 4370-4379.
26. S.J. Yeaman, J.L. Armstrong, S.M. Bonavaud, D. Poinasamy, L. Pickersgill and R. Halse (2001) Regulation of glycogen synthesis in human muscle cells. Biochem. Soc. Trans. 29(pt. 4), 537-541.
27. H. Harada, J.S. Andersen, M. Mann, N. Terada and S.J. Korsmeyer (2001) p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAB. Proc. Natl. Acad. Sci. USA 98 9666-9670.
28. H. Tang, E. Hornstein, M. Stolovich, G. Levy, M. Livingstone, D. Templeton, J. Avruch and O. Myeyubas (2001) Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol. Cell. Biol 21 8671-8683.
29. C. Hu, S. Pang, X. Kong, M. Velleca and J.C. Lawrence Jr. (1994) Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors. Proc. Natl. Acad. Sci. USA 91 3730-3734.
30. A. Pause, G.J. Belsham, O. Donze, T.A. Lin, J.C. Lawrence and N. Sonenberg (1994) Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371 762-767.
31. T.A. Lin, X. Kong, T.A. Haystead, A. Pause, G. Belsham, N. Sonenberg and J.C. Lawrence Jr. (1994) PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 266 653-656.
32. T.A. Lin, X. Kong, A.R. Saltiel, P.J. Blackshear and J.C. Lawrence Jr. (1995) Control of PHAS-I by insulin in 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway. J. Biol. Chem. 270 18531-18538.
33. S.R. von Manteuffel, A.-C. Gingras, X.F. Ming, N. Sonenberg and G. Thomas (1996) 4E-BP1 phosphorylation is mediated by the FRAP-p70 S6K pathway and is independent of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA. 93 4067-4080.
34. E.J. Brown, P.A. Beal, C.T. Keith, J. Chen, T.B. Shin and S. Schreiber (1995) Control of the p70 kinase by kinase activity of FRAP in vivo. Nature 377 441-446.
35. K. Hara, K. Yonezawa, M.T. Kozlowski, T. Sugimoto, K. Andrabi, Q-P. Weng, M. Kasuga, I. Nishimoto and J. Avruch (1997) Regulation of eIF-4E BP1 phosphorylation by mTOR. J. Biol. Chem. 272 26457-26463.
36. G.J. Brunn, C.C. Hudson, A. Sekulic, J.M. Williams, H. Hosoi, P.J. Houghton, J.C. Lawrence Jr. and R.T. Abraham (1997) Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277 99-101.
37. O. Meyuhas and E. Hornstein (2000) Translational control of TOP mRNAs. N. Sonenberg, J.W.B. Hershey, W.C. Merrick,(Eds) Translation Control of Gene Expression Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 671-693.
38. E.F.C. Blommaart, J.J.F.P. Luiken, P.J.E. Blommaart, G.M. van Woerkom and A.J. Meijer (1995) Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J. Biol. Chem. 270 2320-2326.
39. K. Shigemitsu, Y. Tsujishita, K. Hara, M. Nanahoshi, J. Avruch and K. Yonezawa (1999) Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Possible involvement of autophagy in cultured hepatoma cells. J. Biol. Chem. 274 1058-1065.
40. I. Conlon and M. Raff (1999) Size control in animal development. Cell 96 235-244.
41. C.J. Sherr (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60 3689-3695.
42. S. Hashemolhosseini, Y. Nagamine, S.J. Morley, S. Desrivieres, L. Mercep and S. Ferrari (1998) Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and proteinstability. J. Biol. Chem. 273 14424-14429.
43. N. Olashaw and W.J. Pledger (2002) Paradigms of growth control: relation to Cdk activation. Sci. STKe 134 RE7.
44. P.F. Dijkers, R.H. Medema, C. Pals, L. Banerji, N.S. Thomas, E.W. Lam, B.M. Burgering, J.A. Raaijmakers, J.W. Lammers, L. Koenderman and P.J. Coffer (2000) Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol. Cell. Biol. 20 9138-9148.
45. L. Hengst and S.I. Reed (1996) Translational control of p27Kip1 accumulation during the cell cycle. Science 271 1861-1864.
46. M. Pagano, S.W. Tam, A.M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P.R. Yew, G.F. Draetta and M. Rolfe (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269 682-685.
47. C.J. Sherr and J.M. Roberts (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 1501-1512.
48. J. Nourse, E. Firpo, W.M. Flanagan, S. Coats, K. Polyak, M.H. Lee, J. Massague, G. Crabtree and J. Roberts (1994) Interleukin-2-mediated elimination of the p27 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372 570-573.
49. R. Mamillapalli, N. Gavrilova, V.T. Mihaylova, L.M. Tsvetkov, H. Wu, H. Zhang and H. Sun (2001) PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr. Biol. 11 263-267.
50. T. Tsukiyama, N. Ishida, M. Shirane, Y.A. Minamishima, S. Hatakeyama, M. Kitagawa, K. Nakayama and K. Nakayama (2001) Down-regulation of p27Kip1 expression is required for development and function of T cells. J. Immunol. 166 304-312.
51. S.O. Marx and A.R. Marks (2001) Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 104 852-855.
52. M. Castedo, K.F. Ferri and G. Kroemer (2002) Mammalian target of rapamycin (mTOR): pro-andanti-apoptotic. Cell Death Diff. 9 99-100.
53. S. Huang and P.J. Houghton (2002) Inhibitors of mammalian target of rapamycin as a novel antitumor agents: from bench to clinic. Curr. Opin. Invest. Drugs 3 295-304.
54. M. Aoki, E. Blazek and P.K. Vogt (2000) A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc. Natl. Acad. Sci. USA 98 136-141.
55. M.S. Neshat, I.K. Mellinghoff, C. Tran, B. Stiles, G. Thomas, R. Petersen, P. Frost, J.J. Gibbons, H. Wu and C.L. Sawyers (2001) Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc. Natl. Acad. Sci. USA 98 10314-10319.
56. K. Podsypanina, R.T. Lee, C. Politis, I. Hennessy, A. Crane, J. Puc, M. Neshat, H. Wang, L. Yang, J. Gibbons, P. Frost, L. Ellenson and R. Parsons (2001) An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/-mice. Proc. Natl. Acad. Sci. USA 98 10320-10325.
57. I.D. Louro, P. McKie-Bell, H. Gosnell, B.C. Brindley, R.P. Bucy and J.M. Ruppert (1999) The zinc finger protein GLI induces cellular sensitivity to the mTOR inhibitor rapamycin. Cell Growth Differ 10 503-516.
58. T. Yakahashi, K. Hara, K. Inoue, Y. Kawa, C. Tokunaga, S. Hidayat, K. Yoshino, Y. Kuroda and K. Yonezawa (2000) Carboxyl-terminal region conserved among phosphoinositide-kinase-related kinases is indispensable for mTOR function in vivo and in vitro. Genes Cells 5 765-767.
59. J. Choi, J. Chen, S.L. Schreiber and J. Clardy (1996) Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science 273 239-242.
60. B. Menand, T. Desnos, L. Nussaume, F. Berger, D. Bouchez, C. Meyer and C. Robaglia (2002) Expression and disruption of the Arabidopsis TOR (target of rapamycin) gene. Proc. Natl. Acad. Sci. USA 99 6422-6477.
61. R. Weisman and M. Choder (2001) The fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serine. J. Biol. Chem. 276 7027-7032.
62. M.R. Groves, N. Hanlon, P. Turowski, B.A. Hemmings and D. Barford (1999) The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs. Cell 96 99-110.
63. J. Kunz, U. Schneider, I. Howald, A. Schmidt and M.N. Hall (2002) HEAT repeats mediate plasma membrane localization of Tor2p in yeast. J. Biol. Chem. 275 37011-37020.
64. J.E. Kim and J. Chen (2000) Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation. Proc. Nat. Acad. Sci. USA 97 14340-14345.
65. G.J. Brunn, C.C. Hudson, A. Sekulic, J.M. Williams, H. Hosoi, P.J. Houghton, J.C. Lawrence Jr. and R.T. Abraham (1997) Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277 99-101.
66. J.C. Lawrence Jr. and G.J. Brunn (2001) Insulin signaling and the control of PHAS-1 phosphorylation. Prog. Mol. Subcell. Biol. 26 1-31.
67. A.-C. Gingras, B. Raught and N. Sonenberg (2001) Control of translation by the target of rapamycin proteins. Prog. Mol. Subcell. Biol. 27 143-174.
68. P.E. Burnett, R.K. Barrow, N.A. Cohen, S.H. Snyder and D.M. Sabatini (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Nat. Acad. Sci. USA 95 1432-1437.
69. S. Isotani, K. Hara, C. Tokunaga, H. Inoue, J. Avruch and K. Yonezawa (1999) Immunopurified mammalian target of rapamycin phosporylates and activates p76 S6 kinase alpha in vitro. J. Biol. Chem. 274 34493-34498.
70. D.H. Kim, D.D. Sarbassov, S.M. Ali, J.E. King, R.R. Latek, H. Erjument-Bromage, P. Tempst and D.M. Sabatini (2002) mTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110 163-175.
71. K. Hara, Y. Maruki, X. Long, K.-I. Yoshiro, N. Oshiro, S. Hidayat, C. Tokunaga, J. Avruch and K. Yonezawa (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110 177-189.
72. M. Hengstschlager, D.M. Rodman, A. Miloloza, E. Hengstschlager-Ottnad, M. Rosner and M. Kubista (2001) Tuberous sclerosis gene products in proliferation control. Mutation Res. 488 233-239.
73. J.P. Cheadle, M.Z.P.Z. Reeve, J.R. Sampson and D. Kwiatkowski (2000) Molecular genetic advances in tuberous sclerosis. Hum. Genet. 107 97-114.
74. N. Ito and G.M. Rubin (1999) gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell 96 529-539.
75. C.J. Potter, H.E. Huang and T. Xu (2001) Drosophila TSC1 functions with TSC2 to antagonize insulin signaling in regulation cell growth, cell proliferation and organ size. Cell 105 357-368.
76. X. Gao and D. Pan (2001) TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev. 15 1383-1392.
77. N. Tapon, N. Ito, B.J. Dickson, J.E. Treisman and I.K. Hariharan (2001) The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 105 345-355.
78. D.J. Kwiatkowski, H. Zhang, J.L. Bandura, K.M. Heiberger, M. Glogauer, N. el-Hashemite and H. Onda (2002) A mouse model of TSC1 reveals sex-depeendent lethality from liver hemangiomas, and up-regulation of p70 S6 kinase activity inTSC1 null cells. Human Mol. Genet. 11 525-534.
79. B.D. Manning, A.R. Tee, M.M. Logsdon, J. Blenis and L.C. Cantley (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin, as a target of the phosphoinositide 3-kinase/Akt pathway. Mol. Cell 10 151-162.
80. J. Avruch, C. Belham, Q. Weng, K. Hara and K. Yonezawa (2001) The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog. Mol. Subcell. Biol. 26 115-154.
81. D.R. Alessi, M.T. Kozlowski, Q.P. Weng, N. Morrice and J. Avruch (1998) 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8 69-81.
82. N. Pullen, P.B. Dennis, M. Andjelkovic, A. Dufner, S.C. Kozma, B.A. Hemmings and G. Thomas (1998) Phosphorylation and activation of, p70s6k by PDK. Science 279 707-710.
83. R.B. Pearson, P.B. Dennis, J.W. Han, N.A. Williamson, S.C. Kozma, R.E. Wettenhall and G. Thomas (1995) The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 14 5279-5287.
84. A. Balendran, R. Currie, C.G. Armstrong, J. Avruch and D.R. Alessi (1999) Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252. J. Biol. Chem. 274 37400-37406.
85. M.R. Williams, J.S. Arthur, A. Balendran, J. van der Kaay, V. Poli, P. Cohen and D. Alessi (2000) The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cell. Curr. Biol. 10 439-448.
86. Q.P. Weng, M. Kozlowski, C. Belham, A. Zhang, M.J. Comb and J. Avruch (1998) Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies. J. Biol. Chem. 273 16621-16629.
87. K. Hara, K. Yonezawa, Q.P. Weng, M.T. Kozlowski, C. Belham and J. Avruch (1998) Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 272 14484-14494.
88. R.T. Peterson, B.N. Desai, J.S. Hardwick and S.L. Schreiber (1999) Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycin associated protein. Proc. Natl. Acad. Sci. USA 96 4438-4442.
89. S.S. Shalm and J. Blenis (2002) Identification of a conserved motif required for mTOR signaling. Curr. Biol. 12 632.
90. S.R. von Manteuffel, P.B. Dennis, N. Pullen, A-C Gingras, N. Snenberg and G. Thomas (1997) The insulin-induced signalling pathway leading to S6 and initiation factor4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k. Mol. Cell. Biol. 17 5426-5436.
91. C.J. Di Como and K.T. Arndt (1996) Nutrients, via the TOR proteins stimulate the association of Tap42 with type 2A phosphatases. Genes Devel. 10 1904-1916.
92. Y. Jiang and J.R. Broach (1999) TOR proteins and protein phosphatase 2A reciprocally regulate Tap42 in controlling cell growth in yeast. EMBO J. 18 2782-2792.
93. E. Jacinto, B. Guo, K.T. Arndt, T. Schmelze and M.N. Hall (2001) TIP41 interacts with TAP42 and negatively regulates in the TOR signaling pathway. Mol. Cell 5 1017-1026.
94. T. Schmelzle and M.N. Hall (2000) TOR, a central controller or cell growth. Cell 103 253-262.
95. S. Inui, K. Kuwahara, J. Mizutani, K. Maeda, T. Kawai, H. Nakayasu and N. Sakaguchi (1995) Molecular cloning of a cDNA clone encoding a phosphoprotein component related to the Ig receptor-mediated signal transduction. J. Immunol. 154 2714-2723.
96. J. Chen, R.T. Peterson and S.L. Schreiber (1998) Alpha 4 associates with protein phosphatases 2A, 4, and 6. Biochem. Biophys. Res. Commun. 247 827-832.
97. M. Nanahoshi, T. Nishiuma, Y. Tsujishita, K. Hara, S. Inuis, N. Sakaguchi and K. Yonezawa (1998) Regulation of protein phosphatase 2A catalytic activity by alpha4 protein and its yeast homolog Tap42. Biochem. Biophys. Res. Commun. 251 520-526.
98. K. Murata, J. Wu and D.L. Brautigan (1997) B cell receptor-associated protein α4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc. Natl. Acad. Sci. USA 94 10624-10629.
99. S. Inui, H. Sanjo, K. Maeda, H. Yamamoto, E. Miyamoto and N. Sakaguchi (1998) Ig receptor binding protein 1 (alpha4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A. Blood 92 539-546.
100. W.H. Ziegler, D.B. Parekh, J.A. LeGood, R.D.H. Whelan, J.J. Kelly, M. Frech, B.A. Hemmings and P.J. Parker (1999) Rapamycin-sensitive phosphorylation of PKC on a carboxyterminal site by an atypical PKC complex. Curr. Biol. 9 522-529.
101. D. Parekh, W. Ziegler, K. Yonezawa, K. Hara and P.J. Parker (1999) Mammalian TOR controls one of two kinase pathways acting upon nPKC and nPKC. J. Biol. Chem. 274 34758-34764.
102. D.B. Parekh, W. Ziegler and P.J. Parker (2000) Multiple pathways control protein kinase C phosphorylation. EMBO J. 19 496-503.
103. V. Kumar, P. Pandey, D. Sabatini, M. Kumar, P.K. Majumder, A. Bharti, G. Carmichael, D. Kufe and S. Kharbanda (2000) Functional interaction between RAFT1/FRAP/mTOR and protein kinase C in the regulation of cap-dependent initiation of translation. EMBO J. 19 1087-1097.
104. P.H. Scott and J.C. Lawrence Jr. (1998) A mammalian target of rapamycin activity by increased camp in 3T3-L1 adipocytes. J. Biol. Chem. 273 34496-34501.
105. P.H. Scott, G.J. Brumn, A.D. Kohn, R.A. Roth and J.C. Lawrence Jr. (1998) Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA 95 7772-7777.
106. A. Sekulic, C.C. Hudson, J.L. Homme, P. Yin, D.M. Otterness, L.M. Karnitz and R.T. Abraham (2000) A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 60 3504-3513.
107. K. Yokoyami, S. Wakisaka, J. Avruch and S.A. Reeves (2002) Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr. Biol. 10 47-50.
108. N. Takei, M. Kawamura, K. Hara, K. Yonezawa and H. Nawa (2001) Brain-derived neurotrophic factor enhances neuronal translation by activating multiple initiation processes comparison with the effects of insulin. J. Biol. Chem. 276 42818-42825.
109. A.-C. Gingras, S.G. Kennedy, M.A. O'Leary, N. Sonenberg and N. Hay (1998) 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt (PKB) signaling pathway. Genes Devel. 12 502-513.
110. B.M. Burgering and P.J. Coffer (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376 599-602.
111. B.T. Nave, M. Ouwens, D.J. Withers, D.R. Alessi and P.R. Shepherd (1999) Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency of protein translation. Biochem. J. 344(pt. 2), 427-431.
112. M. Vilella-Bach, P. Nuzzi, Y. Fang and J. Chen (1999) The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin-associated protein kinase activity and G1 progression. J. Biol. Chem. 274 4266-4272.
113. Y. Fang, M. Vilella-Bach, R. Bachmann, A. Flanigan and J. Chen (2001) Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294 1942-1945.
114. D.M. Sabatini, R.K. Barrow, S. Blackshaw, P.E. Burnett, M.M. Lai, M.E. Field, B.A. Bahr, J. Kirsch, H. Betz and S.H. Snyder (1999) Interaction of RAFT1 with gephyrin required for rapamycinsensitive signaling. Science 284 1161-1164.
115. H.L. Fox, S.R. Kimball, L.S. Jefferson and C.J. Lynch (1998) Amino acids stimulate phosphorylation of p70S6k and organization, of rat adipocytes into multicellular clusters. Am. J. Physiol. 274 C206-C213.
116. M.E. Patti, E. Brambilla, L. Luzi, E.J. Landaker and C.R. Kahn (1998) Bidirectional modulation of insulin action by amino acids. J. Clin. Invest. 101 1519-1529.
117. X. Wang, L.E. Campbell, C.M. Miller and C.G. Proud (1998) Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem. J. 334 261-267.
118. G.J. Brunn, J. Williams, C. Sabers, G. Wiederrecht, J.C. Lawrence Jr. and R.T. Abrahm (1996) Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitor, wortmannin and LY294002. EMBO J. 15 5256-5267.
119. C.J. Lynch (2001) Role of leucine in the regulation of mTOR by amino acids: revelations from structure-activity studies. J. Nutr. 131 861-865.
120. J.C. Anthony, T.G. Anthony, S.R. Kimball and L.S. Jefferson (2001) Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J. Nutr. 131 856-860.
121. S.R. Kimball and L.S. Jefferson (2002) Control of protein synthesis by amino acid availability. Curr. Opin. Clin. Nutr. Metab. Care 5 63-67.
122. J.C. Anthony, C.H. Lang, S.J. Crozier, T.G. Anthony, D.A. MacLean, S.R. Kimball and L.S. Jefferson (2002) Contribution of insulin to the translational control of protein synthesis in skeletal muscle by leucine. Am. J. Physiol. Endocrinol. 282 1092-1101.
123. J.C. Anthony, A.K. Reiter, T.G. Anthony, S.J. Crozier, C.H. Lang, D.A. Maclean, S.R. Kimball and L.S. Jefferson (2000) Orally administered leucine enhances protein synthesis in skeletal muscle of diabetic rats in the absence of increases in 4E-BP1 or S6K1 phosphorylation. Diabetes 51 928-936.
124. G.E. Mortimore, J.J. Wert Jr., G. Miotto, R. Venerando and M. Kadowaki (1994) Leucine-specific binding of photoreactive Leu7-MAP to a high molecular weight protein on the plasma membrane of the isolated rat hepatocytes. Biochem. Biophys. Res. Commun. 203 200-208.
125. E. Kardalinou, N. Zhelev, C.A. Hazzalin and L.C. Mahadevan (1994) Anisomycin and rapamycin define an area upstream of p70/85S6k containing a bifurcation to histone H3-HMG-like protein phosphorylation and c-fos-c-jun induction. Mol. Cell Biol. 14 1066-1074.
126. A.M. Gressner and I.G. Wool (1974) The stimulation of the phosphorylation of ribosomal protein S6 by cycloheximide and puromycin. Biochem. Biophys. Res. Commun. 60 1482-1490.
127. K. Khaleghpour, S. Pyronnet, A.-C. Gingras and N. Sonenberg (1999) Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities. Mol. Cell Biol. 19 4302-4310.
128. D. Chatterji and A.K. Ojha (2001) Revisiting the stringent response, ppGpp and starvation signaling. Curr. Opin. Microbiol. 4 160-165.
129. Y. Iiboshi, P.J. Papst, H. Kawasome, H. Hosoi, R.T. Abraham, P.J. Houghton and N. Terada (1999) Amino acid-dependent control of p70(s6k). Involvement of tRNA aminoacylation in the regulation. J. Biol. Chem. 274 1092-1099.
130. H. Qui, J. Dong, C. Hu, C.S. Francklyn and A.G. Hinnenbusch (2001) The tRNA-binding moiety in GCN2 contains a dimerization domain that interacts with the kinase domain and is required for tRNA binding and kinase activation. EMBO J. 20 1425-2438.
131. J.W. Pollard, T. Lam and C.P. Stanners (1980) Mammalian cells do not have a stringent response. J. Cell Physiol. 105 313-325.
132. J. Patel, X. Wang and C. Proud (2001) Glucose experts a permissive effect on the regulation of the initiation factor 4E binding 4E-BP1. Biochem. J. 358 497-513.
133. P.B. Dennis, A. Jaeschke, M. Saitoh, B. Fowler, S.C. Kozama and G. Thomas (2001) Mammalian TOR: a homeostatic ATP sensor. Science 294 1102-1105.
134. D.G. Hardie and S.A. Hawley (2001) AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23 1112-1119.
135. B.E. Kemp, K.I. Mitchelhill, D. Stapelton, B.J. Michael, Z.P. Chen and L.A. Witters (1999) Trends Biochem Sci. 24 22-25.
136. D.R. Bolster, S.J. Crozier, S.R. Kimball and L.S. Jefferson (2002) AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J. Biol. Chem. 277 23977-23980.